39 new drugs included in price control list

Janjivan Bureau
New Delhi: The Central Government’s latest effort to improve affordability of medicines, included 39 new medicines in price control list. The new medicines commonly used as diabetes drugs to antibiotics.
A notice posted on the National Pharmaceutical Pricing Authority (NPPA) website late on Wednesday detailed the 39 new drugs, which extend a price control list that already includes more than 652 medicines.
New drugs added to the list include commonly used antibiotics such as azithromycin, combinations of metformin for diabetes, as well as the anti-emetic domperidone.
The move impacts multinational drugmakers, like Abbott Laboratories (ABT.N) and GlaxoSmithKline Plc (GSK.L), and a number of local firms, including Lupin Ltd (LUPN.NS), Cadila Healthcare Ltd (CADI.NS) and Ipca Ltd (IPCA.NS), all of whom sell drugs added to the list.